How big is the Europe Diabetes Drugs Market?

The Europe Diabetes Drugs Market size is expected to reach USD 16.43 billion in 2024 and grow at a CAGR of 4.25% to reach USD 20.23 billion by 2029. Read More

What is the current Europe Diabetes Drugs Market size?

In 2024, the Europe Diabetes Drugs Market size is expected to reach USD 16.43 billion. Read More

Who are the key players in Europe Diabetes Drugs Market?

Eli Lilly, Astrazeneca, Novo Nordisk, Sanofi and Boehringer Ingelheim are the major companies operating in the Europe Diabetes Drugs Market. Read More

What years does this Europe Diabetes Drugs Market cover, and what was the market size in 2023?

In 2023, the Europe Diabetes Drugs Market size was estimated at USD 15.73 billion. The report covers the Europe Diabetes Drugs Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Diabetes Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Diabetes Drugs Market - Size, Share & Trends Analysis

Europe Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Europe Diabetes Drugs Companies and It is Segmented Into Drugs (insulin Drugs (basal or Long-Acting Insulins, Bolus or Fast-Acting Insulins, Traditional Human Insulins, and Biosimilar Insulins), Oral Anti-Diabetic Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine D2 Receptor Agonist, Sglt-2 Inhibitors, Dpp-4 Inhibitors, Sulfonylureas, and Meglitinides), Non-Insulin Injectable Drugs (GLP-1 Receptor Agonists and Amylin Analogue), and Combination Drugs (insulin Combinations and Oral Combinations)) and Geography (United Kingdom, Germany, Italy, Spain, France, Russia, and the Rest of Europe). The Report Offers the Value (in USD) for the Above Segments.

Europe Diabetes Drugs Industry Overview

The European Diabetes Drugs Market is fragmented with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones. These measures taken by the market players will ensure a competitive marketplace, forcing companies to experiment with new technologies.